Long non-coding RNAs, lipid metabolism and cancer (Review)

被引:1
作者
Zhang, Zhen Dong [1 ,2 ]
Hou, Xin Rui [1 ,2 ]
Cao, Xiao Lan [1 ,2 ]
Wang, Xiao Ping [2 ,3 ,4 ]
机构
[1] Xizang Minzu Univ, Grad Sch, Xianyang 712082, Shaanxi, Peoples R China
[2] Xizang Minzu Univ, Mat Med Tibetan Med Res Ctr Tibet,Sch Med, Joint Lab Res Act Components & Pharmacol Mech Tibe, Key Lab High Altitude Hypoxia Environm & Life Hlth, Xianyang 712082, Shaanxi, Peoples R China
[3] Xizang Minzu Univ, Sch Med, Xianyang 712082, Shaanxi, Peoples R China
[4] Xizang Minzu Univ, Sch Med, 6 Wenhui East Rd, Xianyang 712082, Shaanxi, Peoples R China
关键词
long non-coding RNA; lipid metabolism; cancer; signal transduction; therapy; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; HULC; PROLIFERATION; PERSPECTIVES; PROMOTE; SNHG16; CELLS;
D O I
10.3892/etm.2023.12169
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cancer has emerged as the most common cause of death in China. The change in lipid metabolism has been confirmed to have a role in several tumor types, such as esophageal, gastric, colorectal and liver cancer. Cancer cells use lipid metabolism for energy and then rapidly proliferate, invade and migrate. The main pathway by which cancer cell lipid metabolism influences cancer progression is increased fatty acid synthesis. Long non-coding (lnc)RNAs are impor-tant ncRNAs that were indicated to have significant roles in the development of human tumors. They are considered poten-tial tumor biomarkers. Increased lipid synthesis or uptake due to deregulation of lncRNAs contributes to rapid tumor growth. In the present review, current studies on the relation-ship between lncRNAs, lipid metabolism and the occurrence and development of tumors were collated and summarized, and their mechanism of action was discussed. The review is expected to provide a theoretical basis for tumor treatment and prognosis evaluation based on the effective regulation of lncRNAs and lipid metabolism.
引用
收藏
页数:10
相关论文
共 87 条
  • [1] Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers
    Abdi, Esmat
    Latifi-Navid, Saeid
    Abdi, Fatemeh
    Taherian-Esfahani, Zahra
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (11) : 1121 - 1138
  • [2] Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance
    Bacci, Marina
    Lorito, Nicla
    Smiriglia, Alfredo
    Morandi, Andrea
    [J]. TRENDS IN CANCER, 2021, 7 (03): : 198 - 213
  • [3] Cancer Focus Lipid metabolism and cancer
    Bian, Xueli
    Liu, Rui
    Meng, Ying
    Xing, Dongming
    Xu, Daqian
    Lu, Zhimin
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (01)
  • [4] LINC00467, Driven by Copy Number Amplification and DNA Demethylation, Is Associated with Oxidative Lipid Metabolism and Immune Infiltration in Breast Cancer
    Bo, Hao
    Zhang, Wancong
    Zhong, Xiaoping
    Chen, Jiasheng
    Liu, Yang
    Cheong, Kit-Leong
    Fan, Pengju
    Tang, Shijie
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [5] Lipid metabolism in cancer: New perspectives and emerging mechanisms
    Broadfield, Lindsay A.
    Pane, Antonino Alejandro
    Talebi, Ali
    Swinnen, Johannes, V
    Fendt, Sarah-Maria
    [J]. DEVELOPMENTAL CELL, 2021, 56 (10) : 1363 - 1393
  • [6] Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma
    Buechler, Christa
    Aslanidis, Charalampos
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2020, 1865 (05):
  • [7] Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
    Butler, Lisa M.
    Perone, Ylenia
    Dehairs, Jonas
    Lupien, Leslie E.
    de Laat, Vincent
    Talebi, Ali
    Loda, Massimo
    Kinlaw, William B.
    Swinnen, Johannes V.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2020, 159 : 245 - 293
  • [8] CCAT1/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K/AKT/mTOR signalling in lung adenocarcinoma
    Chen, Jing
    Alduais, Yaser
    Zhang, Kai
    Zhu, Xiaoli
    Chen, Baoan
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (19) : 9199 - 9213
  • [9] ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway
    Chen, Junru
    Ding, Chaofeng
    Chen, Yunhao
    Hu, Wendi
    Yu, Chengkuan
    Peng, Chuanhui
    Feng, Xiaode
    Cheng, Qiyang
    Wu, Wenxuan
    Lu, Yuejie
    Xie, Haiyang
    Zhou, Lin
    Wu, Jian
    Zheng, Shusen
    [J]. CANCER LETTERS, 2021, 502 : 154 - 165
  • [10] Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming
    Chen, Muhua
    Zhang, Chunfeng
    Liu, Wei
    Du, Xiaojuan
    Liu, Xiaofeng
    Xing, Baocai
    [J]. MOLECULAR THERAPY, 2022, 30 (06) : 2354 - 2369